Incidence of arrhythmia in chronic lymphocytic leukemia (CLL) patients treated with ibrutinib: a real-world retrospective analysis from two Italian centers.

被引：0
|
作者：
Murru, Roberta
Innocenti, Idanna
Galitzia, Andrea
Tomasso, Annamaria
Oggianu, Valeria
Laurenti, Luca
La Nasa, Giorgio
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553534
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [41] Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
    Yazdy, Maryam Sarraf
    Mato, Anthony R.
    Roeker, Lindsey E.
    Jarral, Umair
    Ujjani, Chaitra S.
    Shadman, Mazyar
    Skarbnik, Alan
    Whitaker, Kate J.
    Deonarine, Isaac
    Kabel, Charlene C.
    Stump, Sarah E.
    Goodfriend, Julie
    Pagel, John M.
    Bailey, Neil
    Patel, Krish
    Jacobs, Ryan
    Feldman, Tatyana A.
    Leslie, Lori A.
    Goy, Andre
    Coombs, Catherine C.
    Muluneh, Benyam
    Khajavian, Sirin
    Lamanna, Nicole
    Weissbrot, Hanna
    Weiss, Jessica
    Cheson, Bruce D.
    BLOOD, 2019, 134
  • [42] Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group
    Winqvist, Maria
    Asklid, Anna
    Andersson, P. O.
    Karlsson, Karin
    Karlsson, Claes
    Lauri, Birgitta
    Lundin, Jeanette
    Mattsson, Mattias
    Norin, Stefan
    Sandstedt, Anna
    Hansson, Lotta
    Osterborg, Anders
    HAEMATOLOGICA, 2016, 101 (12) : 1573 - 1580
  • [43] Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL): An Analysis of a Large Cohort of Patients Treated in Routine Clinical Practice
    Parikh, Sameer A.
    Chaffee, Kari Rabe
    Call, Timothy G.
    Ding, Wei
    Leis, Jose F.
    Chanan-Khan, Asher
    Bowen, Deborah A.
    Conte, Michael
    Van Dyke, Daniel L.
    Hanson, Curtis A.
    Schwager, Susan M.
    Slager, Susan L.
    Kay, Neil E.
    Shanafelt, Tait D.
    BLOOD, 2015, 126 (23)
  • [44] DECREASED EXPRESSION OF ADHESION MOLECULES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS OF PATIENTS TREATED WITH IBRUTINIB
    Guarini, A.
    De Propris, M. S.
    Milani, M. L.
    Intoppa, S.
    Faraone, S.
    Peragine, N.
    Mariglia, P.
    Puzzolo, M. C.
    Mauro, F. R.
    Del Giudice, I.
    Foa, R.
    HAEMATOLOGICA, 2017, 102 : 406 - 406
  • [45] Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
    Spacek, Martin
    Smolej, Lukas
    Simkovic, Martin
    Nekvindova, Lucie
    Kristkova, Zlatuse
    Brychtova, Yvona
    Panovska, Anna
    Maslejova, Stanislava
    Bezdekova, Lucie
    Ecsiova, Dominika
    Vodarek, Pavel
    Zuchnicka, Jana
    Mihalyova, Jana
    Urbanova, Renata
    Turcsanyi, Peter
    Lysak, Daniel
    Novak, Jan
    Brejcha, Martin
    Likarova, Tereza
    Vodicka, Prokop
    Baranova, Jana
    Trneny, Marek
    Doubek, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 40 - 47
  • [46] HYPOGAMMAGLOBULINEMIA AND INFECTIONS IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A PROSPECTIVE STUDY
    Cassin, R.
    Noto, A.
    Silvestris, I.
    Barbieri, M.
    Cappello, E.
    Lonati, S.
    Baldini, L.
    Neri, A.
    Reda, G.
    HAEMATOLOGICA, 2019, 104 : 38 - 38
  • [47] REAL-WORLD ECONOMIC OUTCOMES OF FIRST-LINE (1L) IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
    Challagulla, S.
    Lee, P.
    Kistler, K.
    Douyon, L.
    Lai, D.
    Iyengar, R.
    VALUE IN HEALTH, 2021, 24 : S38 - S38
  • [48] Real-world Comparison of Adherence Between Patients with Chronic Lymphocytic Leukemia Treated with Single-agent Ibrutinib or Acalabrutinib In First Line
    Lu Xiaoxiao
    Bruno, Emond
    Laura, Morrison
    Frederic, Kinkead Frederic
    Patrick, Lefebvre
    Helene, Marie-Lafeuille
    Wasiulla, Khan
    Wu Linda
    Zaina, P. Qureshi Zaina P.
    Ryan, Jacobs
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S26 - S26
  • [49] WHAT DO WE KNOW ABOUT THE REAL INCIDENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND WHERE AND HOW ARE THE PATIENTS WITH CLL TREATED?
    Panovska, A.
    Doubek, M.
    Brychtova, Y.
    Pospisilova, S.
    Mayer, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 600 - 600
  • [50] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL)
    Feinberg, Bruce
    Schenkel, Brad
    McBride, Ali
    Ellis, Lorie
    Radtchenko, Janna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S204 - S205
12345